CPGShield resources · Federal cosmetic labeling
A beauty brand wants to make its packaging more welcoming.
So it adds:
Para todo tipo de piel.
One short Spanish phrase.
Simple design decision.
Potentially much bigger labeling consequence.
FDA's cosmetic labeling rules say that if a label or labeling contains a representation in a foreign language, required label information generally must also appear in that language.
The rule is found in 21 CFR 701.2(b).
That means adding one non-English statement can turn a mostly English package into a bilingual-label compliance project.
FDA states that labeling information required by law or regulation generally must appear in English.
There is an exception for products distributed solely in a U.S. territory where another language is predominant, such as Puerto Rico.
For products in the broader U.S. market, English remains the baseline.
FDA's Cosmetic Labeling Guide explains that when a cosmetic label contains a foreign-language representation, the required label statements must also appear in that foreign language.
That is much broader than:
“Translate the marketing sentence you added.”
The brand needs to evaluate the mandatory information across the package.
Depending on the product, required information can include:
The exact translation obligation depends on the applicable labeling provisions.
Cosmetic packaging already has severe space constraints.
A single-language label may need room for:
Now duplicate required information into another language.
The design can become crowded very quickly.
Crowding creates a second compliance problem because mandatory information must remain prominent, conspicuous, and readable.
So the bilingual rule can affect:
A compliance translation is not merely a marketing translation.
The objective is to communicate required information accurately.
A phrase such as:
“For external use only”
cannot be treated casually if it is part of a warning.
Neither can product identity, directions, or other mandatory statements.
Poor translation can create ambiguity even when both languages appear on the package.
Cosmetic ingredient nomenclature has its own rules.
FDA provides separate resources regarding cosmetic ingredient names and labeling products for international markets.
Brands should not assume that every standardized ingredient name should simply be translated word-for-word.
The ingredient declaration needs to follow the applicable U.S. nomenclature framework while also satisfying any language requirements that apply to the label.
This is one area where “just run the panel through a translation tool” can create more confusion.
This is where labels become fact-specific.
Not every foreign-looking brand or fanciful product name automatically has the same effect as full foreign-language labeling.
The regulatory analysis depends on what the wording represents and how the label is presented.
A brand should be careful about building a general rule from one design example.
The safest workflow is to identify every foreign-language representation and then evaluate 21 CFR 701.2(b) against the actual package.
FDA notes an exception for products distributed solely in a territory where another language is predominant.
Puerto Rico is the obvious example.
But a national product sold both in Puerto Rico and throughout the mainland United States may need a different strategy from a product distributed solely in Puerto Rico.
Distribution geography is therefore part of the label analysis.
Suppose the original ingredient panel used 1/16-inch lettering.
The brand adds Spanish copy.
The designer reduces everything to make it fit.
Now the language issue may be solved while a type-size issue is created.
This is why content and artwork review should not be separated. The right words can still fail the artwork review covers the measurable side.
A legally correct translation can still be displayed incorrectly.
Required labeling information generally must appear in English, subject to the territorial exception described by FDA.
FDA states that if labeling contains a foreign-language representation, required labeling information generally must also appear in that language.
Cosmetic ingredient nomenclature has separate rules. Brands should follow FDA's ingredient-name requirements rather than simply translating standardized names informally.
Mandatory information still needs to meet applicable prominence, conspicuousness, and type-size requirements.
FDA recognizes an exception for products distributed solely in a U.S. territory where another language is predominant. Distribution circumstances matter.
Bilingual packaging is a perfect example of why a final label scan matters.
You can solve the translation and accidentally break the typography.
You can fit the typography and accidentally omit required information.
CPGShield checks cosmetic label content and, for supported PDF inputs, measurable artwork properties-so the final package can be reviewed as a package rather than a collection of separate text documents.
→ Run your U.S. cosmetic label through CPGShield before print
A text scan is free. Measuring supported print-ready PDFs costs one check credit; supported PDF corrections cost one additional check credit. Unsupported or unreadable artwork checks remain unverified and require review before printing.
Especially after a translation, redesign, or market expansion.
This article is educational and does not constitute legal advice.
Free cosmetic label compliance check. No demo required, no card. CPGShield LLC provides independent screening. We are not affiliated with, endorsed by, or acting for any retailer, brand, agency or organization we name.